Clinical Trials Directory

Trials / Completed

CompletedNCT00600431

Melanocytic Nevi in Children Under Chemotherapy

Melanocytic-Nevi-Counts During Chemotherapy of Children With Malignancies.

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Changes in nevus count in 16 children (8m, 8f) aged between 2 and 17 years (median:8 years) suffering from different malignancies were examined every three months during a one-year period after starting chemotherapy. An age and sex matched control group underwent the same skin examinations.At the start of our study, the range of number of nevi in the chemotherapy group was 0-133, in the control group 2-199.

Detailed description

Objectives: Patients given chemotherapy because of different malignancies have an increased susceptibility to cutaneous tumours and infection and a change of number of nevi during treatment is discussed. We investigated wether total nevi count changes in children undergoing chemotherapy. Therefore 16 (8m, 8f) children suffering from leukaemia (11), lymphoma (2), adenosarcoma of the kidney (1), Ewing´s sarcoma (1) and neuroblastoma (1) aged between 2 and 17 years (median:8 years), under chemotherapy at the pediatric department of oncology, were examined at the beginning and 9-12 months after starting chemotherapy. As control group age and sex matched children of the local population were used. Materials and Methods: At the beginning of chemotherapy the nevi were counted on the total body. All nevi were larger in diameter than 1mm and as melanocytic lesion identifiable. Clinical and dermoscopic photographs were taken of every nevus. If the patient had more than 50 nevi, only nevi on the face, right arm, upper back and the buttocks were documented. Reassessment was repeated every 3 month. Conclusion: In our patients under chemotherapy during one year the development of new nevi is similar to sex and age matched children of the general population. During this short period development of nevi seems not to be influenced by chemotherapy.

Conditions

Timeline

Start date
2006-02-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2008-01-25
Last updated
2008-01-25

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00600431. Inclusion in this directory is not an endorsement.